High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma.
about
Vitamin D and Immune Response: Implications for Prostate Cancer in African AmericansNatural compounds as anticancer agents: Experimental evidenceA Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer.Vitamin D metabolism and action in the prostate: implications for health and disease.CYP24A1 inhibition enhances the antitumor activity of calcitriol.Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer.Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancerVitamin D and cancer: clinical aspects.Vitamin d: are we ready to supplement for breast cancer prevention and treatment?Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directionsRole of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies.Nutrition and physical activity guidelines for cancer survivors.Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer.Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study.Potential attenuation of disease progression in recurrent prostate cancer with plant-based diet and stress reduction.ASCENT: the androgen-independent prostate cancer study of calcitriol enhancing taxotere.Can vitamin D supplementation reduce prostate cancer disparities?Vitamin D in prostate cancer.Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis
P2860
Q26768536-056CE15E-4FD5-4A4C-9526-C4ED222BA535Q26823107-088D1FEB-90D0-403E-9BC5-DA88FB285363Q33462970-806B5D4E-444C-41C9-A764-1FC3B0A76E33Q34027269-B9F81A16-DAA6-4BC2-B9CB-E0F2B3F6D176Q34132307-0708253D-6718-4996-BEB0-E67F153E46E9Q34756280-91A4BA29-72F4-438C-AFD3-3EB042488CEBQ34799393-8B678C91-8167-4193-A28B-CFF8DB344D4BQ35107605-60F2A8C9-0E1C-49F6-9BB9-84F0E053D2A7Q36509508-7C26A6AA-E4E1-4C2D-A06F-15BFBDC55867Q36692336-5F6D30EB-5C21-4409-9A04-773C7AC4077EQ36760953-F0A36E75-F651-45C1-B732-8718543F82D6Q37202773-22FAF880-178E-43C6-A938-06F4710BF5E9Q38005959-A8CD3601-4033-449B-BB3F-015EBDC6C238Q42574095-BC9DB18C-A151-4FB5-80B4-F6D9AF4CE6F2Q44685336-7718BA53-BB5C-41EA-8ED5-5EBA2C4EEF85Q45996176-852338AF-4C7A-40F6-B348-2F11031B8025Q46654013-5D4884F8-A144-45EF-9EDE-14EF800B7A29Q46658342-0C3FE4FA-B821-4511-A3F2-35814396F73BQ55024961-7D7E98A1-3B5D-4FED-9B40-3289ECA3457CQ57818885-C9A60762-CCE1-4860-BCB8-735F53864097
P2860
High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
High-dose weekly oral calcitri ...... iation for prostate carcinoma.
@en
High-dose weekly oral calcitri ...... iation for prostate carcinoma.
@nl
type
label
High-dose weekly oral calcitri ...... iation for prostate carcinoma.
@en
High-dose weekly oral calcitri ...... iation for prostate carcinoma.
@nl
prefLabel
High-dose weekly oral calcitri ...... iation for prostate carcinoma.
@en
High-dose weekly oral calcitri ...... iation for prostate carcinoma.
@nl
P2093
P356
P1433
P1476
High-dose weekly oral calcitri ...... iation for prostate carcinoma.
@en
P2093
Bruce A Lowe
Dianne Lemmon
Tomasz M Beer
W David Henner
P304
P356
10.1002/CNCR.11179
P407
P577
2003-03-01T00:00:00Z